Intelligence Platform
Patents
Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6685944
Modified HCV peptide vaccines
expired patentUS 6682741
&bgr;2 microglobulin fusion proteins and high affinity variants
expired patentUS 6682758
Water-insoluble drug delivery system
expired patentUS 6682728
Efficient and selective adenoviral-mediated gene transfer into vascular neointima
expired patentUS 6680060
Hepatitus A virus vaccines
expired patentUS 6680176
Identification of candidate ligands which modulate antigen presenting cells
expired patentUS 6676936
Chimeric and/or growth-restricted flaviviruses
expired patentUS 6676973
Method of treating ovarian cancers with cadmium
expired patentUS 6673905
Conjugation of biomolecules using Diels-Alder cycloaddition
expired patentUS 6673342
Recombinant human IgA-J chain dimer
expired patentUS 6670374
Swainsonine compounds as inhibitors of toxin receptor expression
expired patentUS 6669962
Starch microcapsules for delivery of active agents
expired patentUS 6669935
Delivery of therapeutic agents by gene therapy
expired patentUS 6664374
Polypeptides comprising IL-6 ligand-binding receptor domains
expired patentUS 6664263
1,8-naphthalimide imidazo{4,5,1-de}acridones with anti-tumor activity
expired patentUS 6664227
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
expired patentUS 6660750
Flavopiridol methods and compositions for HIV therapy
expired patentUS 6660488
Antibodies for the alpha platelet-derived growth factor receptor
expired patentUS 6660273
Chimeric vaccine against tick-borne encephalitis virus
expired patentUS 6656930
Aralkyl diazabicycloalkane derivatives for CNS disorders
expired patentUS 6656706
Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes
expired patentUS 6653505
3-Methoxybenzyl thiourea derivatives and improved lipid compositions containing same
expired patentUS 6653084
Anti-erbB-2 antibodies to human receptor related to but distinct from EGF receptor
expired patentUS 6649411
Methods of inhibiting cancer cells with ADNF III antisense oligonucleotides
expired